ARTICLE | Company News
Roche files for European approval of Pegasys
February 9, 2001 8:00 AM UTC
F. Hoffmann-La Roche (SWX:ROCZ) filed for European marketing approval of its Pegasys PEGylated 40K interferon alfa-2a to treat chronic hepatitis C infection in cirrhotic and non-cirrhotic patients wit...